Seroconversion stages COVID19 into distinct pathophysiological states

COVID19 is a heterogeneous medical condition involving a suite of underlying pathophysiological processes including hyperinflammation, endothelial damage, thrombotic microangiopathy, and end-organ damage. Limited knowledge about the molecular mechanisms driving these processes and lack of staging biomarkers hamper the ability to stratify patients for targeted therapeutics. We report here the results of a cross-sectional multi-omics analysis of hospitalized COVID19 patients revealing that seroconversion status associates with distinct underlying pathophysiological states. Seronegative COVID19 patients harbor hyperactive T cells and NK cells, high levels of IFN alpha, gamma and lambda ligands, markers of systemic complement activation, neutropenia, lymphopenia and thrombocytopenia. In seropositive patients, all of these processes are attenuated, observing instead increases in B cell subsets, emergency hematopoiesis, increased markers of platelet activation, and hypoalbuminemia. We propose that seroconversion status could potentially be used as a biosignature to stratify patients for therapeutic intervention and to inform analysis of clinical trial results in heterogenous patient populations.

Sina plots with boxes indicating median and interquartile range. Number above brackets is p-value for . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. ; https://doi. org/10.1101org/10. /2020 Mann-Whitney test. b. Volcano plots for Spearman correlations between seroconversion indices and circulating plasma proteins detected by mass spectrometry (MS), SOMAscan ® assays, MSD assays, as well as immune cell subsets detected by mass cytometry (MC) among all live cells. X axes show Spearman rho values. Y axes show -log10 p-values adjusted with Benjamini-Hochberg method. Dashed vertical line indicates rho = 0. Dashed horizontal line indicates the statistical cut off of false discovery rate (FDR)=10 (q=0.1). c-g. Representation of gating strategy employed during mass cytometry analysis of peripheral immune cell lineages. In (c), single live cells were gated for CD45+ staining followed by gating into T cells (CD3+), B cells (CD3-CD19+), and CD4+ and CD8+ T cells subsets. In (d), B cells were further gated into the indicated subsets. In (e) and (f), CD4+ and CD8+ T cell lineages were further characterized in the indicated subsets. Panel (g) shows gating for the indicated myeloid subsets and Natural Killer (NK) cells.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted December 7, 2020. ;https://doi.org/10.1101https://doi.org/10. /2020  CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.05.20244442 doi: medRxiv preprint 40 indicated immune cell types comparing controls (Negative, Neg.) to COVID19 patients divided into seroconversion low (Low) and high (High) status. Data are presented as modified Sina plots with boxes indicating median and interquartile range. Number above brackets is Q-value for Mann-Whitney tests.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.05.20244442 doi: medRxiv preprint CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. and high (High) status. Number above brackets is p-value for Mann-Whitney tests.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. and high (High) status. Number above brackets is p-value for Mann-Whitney tests.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10.1101/2020.12.05.20244442 doi: medRxiv preprint SUPPLEMENTARY FILES LEGENDS Supp. File S1. Cohort characteristics. Table summarizing cohort characteristics. Information pertaining less than 10% of the cohort is indicated as <10% to prevent potential reidentification. In each tab, column A indicates the population measured, column B indicates parent lineage, column C indicates the Spearman rho value, column D indicates the p value, and column E indicates the adjusted p value using the Benjamini-Hochberg method.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted December 7, 2020. Supp. File S12. Immune cell type definition. List of immune cell subsets defined by mass cytometry.
Column A indicates the population identified, column B indicates definition based on gating strategy employed, and column C indicates the parent lineage.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted December 7, 2020. ; https://doi.org/10. 1101/2020